International Cannabis Weekly: 338

BREAKING: GERMANY’S CANNABIS LEGALISATION BILL PASSES WITH LARGE MAJORITY

In a milestone moment for European cannabis, Germany has officially passed its cannabis bill following months of intense debate and a number of holdups.

READ MORE  »

DRAFT OF MEDICAL CANNABIS FRAMEWORK PUBLISHED IN SPAIN – WITH FLOWER OMITTED

READ MORE »

MEDICAL CANNABIS DIVISION OF ROKSHAW LTD REBRANDING TO CURALEAF LABORATORIES

READ MORE »

• Police union urges German chancellor, Olaf Scholz, to abandon plans for partial legalisation of cannabis.
• HHC products are set to be banned in the Czech Republic following dozens of incidents of child hospitalisations.
• German legislative committee gives green light to cannabis bill before floor vote, concerns raised over timeline.
• Council in Northern Ireland delegates medical cannabis farm decision to planning department.
• Lumino’s forward-thinking vision and innovative talent acquisition strategies in the Europe’s cannabis sector.
• Bedrocan establishes its own Clinical Research Unit in the Netherlands to study the effects of cannabis.

• New Yorkers are one step closer to being able to grow their own cannabis after CCB approves draft homegrow rules.
• FDA report examines cannabis users’ social media posts in cannabis rescheduling review.
• Virginia’s cannabis sales bills diverge on licensing, equity, taxes, and other key aspects.
• Maryland Senate passes legislation safeguarding gun rights for medical cannabis patients.
• Nevada’s inaugural cannabis consumption lounge is set to open by the end of February.
• U.S. Army awards US$1.9 million to a Pennsylvania builder for significant hempcrete research.

GET TICKETS »

• Decibel Cannabis Company establishes itself as leader in infused pre-roll segment with over 50% market share in Canada.
• The cost of adult-use cannabis in Canada decreased by 3.6% in December 2023 compared to the same period last year.
• Mendo Medical announces partnership with Beard Bros Pharms to bring Californian cannabis products to Canada.
• Fewer youths say cannabis is “easy” to access cannabis in Canada post-legalisation.
• During the third quarter, Quebec’s government-owned cannabis retail stores disclosed a net income of CA$33 million.
• Aurora Cannabis announces appointment of a new CFO and successful completion of share consolidation.

• The Constitutional Court in Colombia asks the Ministry of Health to grant medicinal cannabis for chronic pain relief.
• CBD-based Trunerox approved as an add-on treatment in Colombia for patients with Dravet syndrome and LGS.
• Judge orders Anvisa to allow the entry of cannabis-based product for medicinal purposes in Brazil.
• Xebra Brands executes CBD isolate supply agreement with ICAN Green in Mexico.

• A parliamentary hearing is set to examine whether adult-use cannabis should be legalised in Australia.
• The Bank of Guam announces launch of a banking programme for cannabis industry companies on Guam.
• Australian cultivators have called on medicinal cannabis firms to support local growers.
• TYSON 2.0 continues its international expansion efforts as it enters the market in Thailand.

• CannaPharmaRx finalises a multi-million dollar Israeli supply agreement with Cantek.
• Ministry of Health distributes final version of new category table of medical cannabis products in Israel.